Loading market dashboard
Forte Biosciences, Inc.
FBRXHealthcareNASDAQUS
Loading analysis workspace
Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Forte Biosciences, Inc. · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2030 | $53.42M | $53.42M - $53.42M | $0.00 | -$5.797 | 1 |
| Dec 2029 | $32.44M | $32.44M - $32.44M | $0.00 | -$5.933 | 2 |
| Dec 2028 | $14.31M | $14.31M - $14.31M | $0.00 | -$4.17 | 3 |
| Dec 2027 | $22.50M | $22.50M - $22.50M | $0.00 | -$4.252 | 4 |
| Dec 2026 | $9.00M | $9.00M - $9.00M | $0.00 | -$4.106 | 4 |
| Dec 2025 | $0.00 | $0.00 - $0.00 | $0.00 | -$4.316 | 0 |
| Dec 2024 | $0.00 | $0.00 - $0.00 | $0.00 | -$9.435 | 0 |
| Dec 2021 | $9.6K | $7.7K - $11.5K | -$26.77M | -$34.75 | 20 |
| Dec 2019 | $13.5K | $13.5K - $13.5K | -$34.51M | -$1,057.50 | 10 |
| Dec 2018 | $18.02M | $18.02M - $18.02M | $0.00 | -$792.122 | 11 |
| Dec 2017 | $43.0K | $43.0K - $43.0K | $0.00 | -$997.50 | 11 |